Ultraperformance liquid chromatography tandem mass spectrometric method for direct quantification of salbutamol in urine samples in doping control

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 5, 2009, Pages 886-890

  Ventura, R ^a,b   Ramirez R ^a   Monfort, N ^a,b   Segura, J ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Doping analysis; Isotope dilution; Salbutamol; UPLC MS MS

Indexed keywords

ACETONITRILE; ARGON; FORMIC ACID; NITROGEN; SALBUTAMOL; WATER;

ARTICLE; CONTROLLED STUDY; DOPING; DRUG STRUCTURE; DRUG URINE LEVEL; ELECTROSPRAY; ELUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MONITORING; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; TEMPERATURE; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY; URINALYSIS;

ALBUTEROL; CHROMATOGRAPHY, LIQUID; DOPING IN SPORTS; DRUG STABILITY; HUMANS; MODELS, CHEMICAL; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; TECHNOLOGY, PHARMACEUTICAL; TIME FACTORS; URINALYSIS;

EID: 70349182009     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.06.009     Document Type: Article

References (22)

1. Morton A.R., Papalia S.M., and Fitch K.D. Clin. J. Sport Med. 2 (1992) 93-97
2. World Anti-doping Agency (WADA) http://www.wada-ama.org/rtecontent/document/2009_List_Eng_Final_20_Sept_08.pdf (2008).
3. Martineau L., Horan M.A., Rothwell N.J., and Little R.A. Clin. Sci. 83 (1992) 615-621
4. Caruso J.F., Signorile J.F., Perry A.C., Leblanc B., Williams R., Clark M., and Bamman M.M. Med. Sci. Sports Exerc. 27 (1995) 1471-1476
5. Meeuwisse W.H., McKenzie D.C., Hopkins S.R., and Road J.D. Med. Sci. Sports Exerc. 24 (1992) 1161-1166
6. Morgan D.J. Clin. Pharmacokinet. 18 (1990) 270-294
7. Hussey E.K., Donn K.H., Powell J.R., Lahey A.P., and Pakes G.E. J. Clin. Pharmacol. 31 (1991) 561-564
8. Hindle M., and Chrystyn H. Br. J. Clin. Pharmacol. 34 (1992) 311-315
9. Berges R., Segura J., Ventura R., Fitch K.D., Morton A.R., Farre M., Mas M., and de la Torre X. Clin. Chem. 46 (2000) 1365-1375
10. Ventura R., Segura J., Berges R., Fitch K.D., Morton A.R., Berruezo S., and Jimenez C. Ther. Drug Monit. 22 (2000) 277-282
11. World Anti-doping Agency (WADA) http://www.wada-ama.org/rtecontent/document/Minimum_Required_Performance_Levels_TD_v1_0_January_2009.pdf (2008).
12. Sporer B.C., Sheel A.W., Taunton J., Rupert J.L., and McKenzie D.C. Clin. J. Sport Med. 18 (2008) 282-285
13. Berges R., Segura J., de la Torre X., and Ventura R. J. Chromatogr. B 723 (1999) 173-184
14. Mareck U., Haenelt N., Parr M.K., Guddat S., Thomas A., Thevis M., and Schänzer W. In: Scänzer W., Geyer H., Gotzmann A., and Mareck U. (Eds). Recent Advances in Doping Analysis (15) (2007), Sportvelag Strauss, Köln 87-96
15. Spyridaki M., Kiousi P., Vonaparti A., Valavani P., Zonaras V., Zahariou M., Sianos E., Tsoupras G., and Georgakopoulos C. Anal. Chim. Acta 573-574 (2006) 242-249
16. Pozo O.J., van Eenoo P., Van Thuyne W., Deventer K., and Delbeke F.T. J. Chromatogr. A 1183 (2008) 108-118
17. Damasceno L., Ventura R., Cardoso J., and Segura J. J. Chromatogr. B 780 (2002) 61-71
18. Damasceno L., Ventura R., Ortuno J., and Segura J. J. Mass Spectrom. 35 (2000) 1285-1294
19. Ventura R., Damasceno L., Farre M., Cardoso J., and Segura J. Anal. Chim. Acta 418 (2000) 79-92
20. Forsdahl G., and Gmeiner G. J. Sep. Sci. 27 (2004) 110-114
21. World Anti-doping Agency (WADA) http://www.wada-ama.org/rtecontent/document/International_Standard_for_Laboratories_v6_0_January_2009.pdf (2009).
22. World Anti-doping Agency (WADA) http://www.wada-ama.org/rtecontent/document/criteria_1_2.pdf (2004).